Shorter Antibiotic Duration for Pseudomonas Bacteremia: A Call for Future Trials
Study limitation reported by the research below: “Findings may not generalize to immunocompromised patients or those with complicated bacteremia sources, as the referenced trial focused on uncomplicated cases.”